Quick Answer
BioAtla, Inc. reported Operating Income of -$59.30 million for fiscal year 2025.
BioAtla, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$59.30M | +19.8% |
| 2024 | -$73.94M | +43.0% |
| 2023 | -$129.69M | -19.9% |
| 2022 | -$108.14M | -12.1% |
| 2021 | -$96.44M | -220.4% |
| 2020 | -$30.10M | -6.5% |
| 2019 | -$28.27M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$13.79M | -22.4% | +26.1% |
| June 30, 2025 | -$18.65M | +15.1% | -5.9% |
| March 31, 2025 | -$17.61M | +28.0% | -56.3% |
| September 30, 2024 | -$11.27M | +67.8% | +48.7% |
| June 30, 2024 | -$21.97M | +40.9% | +10.2% |
| March 31, 2024 | -$24.46M | +15.5% | +30.2% |
| September 30, 2023 | -$35.02M | -33.8% | +5.9% |
| June 30, 2023 | -$37.20M | -28.0% | -28.6% |
- BioAtla, Inc. showed an increase of +19.8% in Operating Income compared to the prior fiscal year.
- Over the 2019–2025 period, BioAtla, Inc.’s operating income has declined by 109.8% (from -$28.27 million to -$59.30 million).
- The most recent figure is from BioAtla, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: